Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use

Details for Australian Patent Application No. 2007302245 (hide)

Owner Novartis AG

Inventors Breitenstein, Werner; Von Matt, Anette; Furet, Pascal; Zoller, Thomas; Buehlmayer, Peter; Pirard, Bernard

Agent Davies Collison Cave

Pub. Number AU-A-2007302245

PCT Pub. Number WO2008/037459

Priority 06121416.9 28.09.06 EP

Filing date 26 September 2007

Wipo publication date 3 April 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/037459 Priority application(s): WO2008/037459

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007302249-Means and methods of enhancing delivery to biological systems

2007302243-Apparatus and method for the optical examination of value documents